Accolate (Zafirlukast) - Summary

ACCOLATE SUMMARY

ACCOLATE®
(zafirlukast)
TABLETS

Zafirlukast is a synthetic, selective peptide leukotriene receptor antagonist (LTRA), with the chemical name 4-(5-cyclopentyloxy-carbonylamino-1-methyl-indol-3-ylmethyl) -3-methoxy-N-o-tolylsulfonylbenzamide.

ACCOLATE is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older.

ACCOLATE NEWS HIGHLIGHTS

Media Articles Related to Accolate (Zafirlukast)

Lower Weight Equals Lower Symptom Burden in Asthma
Source: MedPageToday.com - Latest medical news and health news plus CME for physicians and healthcare professionals [2008.09.04]

Health Tip: Controlling Asthma (HealthDay)
Source: Y! Health News Search RSS Feed [2008.09.04]

Obesity makes asthma worse (Reuters)
Source: Y! Health Asthma News [2008.09.04]

Innate Immune System Targets Asthma-Linked Fungus For Destruction
Source: Allergy News From Medical News Today [2008.09.03]

Asthma rates high among abused children (Reuters)
Source: Y! Health Asthma News [2008.09.03]

more>>

Published Studies Related to Accolate (Zafirlukast)

Effects of zafirlukast on capsular contracture: controlled study measuring the mammary compliance. [2007.07]

[Nasal budesonide plus zafirlukast vs nasal budesonide plus loratadine-pseudoephedrine for controlling the symptoms of rhinitis and asthma] [2005.03]

Treatment of category III A prostatitis with zafirlukast: a randomized controlled feasibility study. [2005.03]

Leukotriene E(4)-induced persistent eosinophilia and airway obstruction are reversed by zafirlukast in patients with asthma. [2005.02]

The effects of add-on zafirlukast treatment to budesonide on bronchial hyperresponsiveness and serum levels of eosinophilic cationic protein and total antioxidant capacity in asthmatic patients. [2004.12]

more>>